Publication Archives - Page 2 of 3 - DC-ren

Physicians & academics Publication

February 19, 2024

Randomized Trial of SGLT2 Inhibitor Identifies Target Proteins in Diabetic Kidney Disease

Tarunveer S. Ahluwalia, Teemu K.E. Rönkkö, Mie K. Eickhoff, Viktor Rotbain Curovic, Justyna Siwy, Susanne…

Susanne

Love0

Industry & stakeholders Physicians & academics Publication

December 14, 2023

DC-ren associated studies

The concept of precision medicine as proposed by DC-ren is also of great interest to…

Christof Simon

Love0

Physicians & academics Publication

November 29, 2023

Randomized Trial of SGLT2 Inhibitor Identifies Target Proteins in Diabetic Kidney Disease.

Ahluwalia TS, Rönkkö TKE, Eickhoff MK, Curovic VR, Siwy J, Eder S, Denicolò S, Mayer…

Christof Simon

Love0

Physicians & academics Publication

November 17, 2023

Combination Therapy of RAS Inhibition and SGLT2 Inhibitors Decreases Levels of Endotrophin in Persons with Type 2 Diabetes.

Møller AL, Thöni S, Keller F, Sharifli S, Rasmussen DGK, Genovese F, Karsdal MA, Mayer…

Christof Simon

Love0

Physicians & academics Publication

November 1, 2023

Candidate composite biomarker to inform drug treatments for diabetic kidney disease.

Jones RD, Abebe S, Distefano V, Mayer G, Poli I, Silvestri C, Slanzi D.Front Med…

Christof Simon

Love0

Physicians & academics Publication

October 31, 2023

Urinary peptide analysis to predict the response to blood pressure medication

Jaimes Campos MA, Mavrogeorgis E, Latosinska A, Eder S, Buchwinkler L, Mischak H, Siwy J,…

Diana Derias

Love0

Physicians & academics Publication

September 14, 2023

Prognosis and Personalized In Silico Prediction of Treatment Efficacy in Cardiovascular and Chronic Kidney Disease: A Proof-of-Concept Study.

Jaimes Campos MA, Andújar I, Keller F, Mayer G, Rossing P, Staessen JA, Delles C,…

Christof Simon

Love0

Physicians & academics Publication

August 31, 2023

Exploratory Study Analyzing the Urinary Peptidome of T2DM Patients Suggests Changes in ECM but Also Inflammatory and Metabolic Pathways Following GLP-1R Agonist Treatment.

Lohia S, Siwy J, Mavrogeorgis E, Eder S, Thöni S, Mayer G, Mischak H, Vlahou…

Christof Simon

Love0

Physicians & academics Publication

June 6, 2023

Effect of treatment with GLP-1R agonists on the urinary peptidome of T2DM patients

Lohia S, Siwy J, Mavrogeorgis E, Eder S, Thoeni S, Mayer G, Mischak H, Vlahou…

Christof Simon

Love0

Physicians & academics Publication

April 4, 2023

Presence of retinopathy and incident kidney and cardiovascular events in type 2 diabetes with normoalbuminuria – A post-hoc analysis of the PRIORITY randomized clinical trial.

Curovic VR, Tofte N, Lindhardt M, Adamova K, Bakker SJL, Beige J, Beulens JWJ, Birkenfeld…

Christof Simon

Love0

© 2020 by the DC-ren consortium